XML 37 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Financial Instruments
12 Months Ended
Dec. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial Instruments Financial Instruments
Off-Balance Sheet Risk
As collateral for the Company's performance and to insurers, the Company is contingently liable under standby letters of credit, bonds and bank guarantees in the amounts of $285.4 million, $275.4 million and $273.1 million at December 31, 2018, 2017 and 2016, respectively. These standby letters of credit, bonds and bank guarantees are generally in force for up to 2 years. Certain issues have no scheduled expiration date. The Company pays fees to various banks and insurance companies that range from 0.4% to 3.9% per annum of the instrument's face value. If the Company were required to obtain replacement standby letters of credit, bonds and bank guarantees at December 31, 2018 for those currently outstanding, it is the Company's opinion that the replacement costs would be within the present fee structure.
The Company has currency exposures in approximately 30 countries. The Company's primary foreign currency exposures during 2018 were in the European Union, the U.K. and Brazil.
Off-Balance Sheet Risk—Third-Party Guarantees
During June 2014, the Company provided a guarantee to Brand as part of the net working capital settlement related to the Infrastructure Transaction, for certain matters occurring prior to closing. The remaining term of this guarantee is 2 years at December 31, 2018. The maximum potential amount of future payments related to this guarantee is approximately $3 million at December 31, 2018. There is no recognition of this potential future payment in the consolidated financial statements as the Company believes the potential for making this payment is remote.
Any liabilities related to the Company's obligation to stand ready to act on third-party guarantees are included in Other current liabilities or Other liabilities (as appropriate) on the Consolidated Balance Sheets. Any recognition of these liabilities did not have a material impact on the Company's financial position or results of operations for 2018, 2017 or 2016.
In the normal course of business, legal indemnifications are provided related primarily to the performance of the Company's products and services and patent and trademark infringement of the products and services sold. These indemnifications generally relate to the performance (regarding function, not price) of the respective products or services and therefore no liability is recognized related to the fair value of such guarantees.
Derivative Instruments and Hedging Activities
The Company uses derivative instruments, including foreign currency exchange forward contracts, interest rate swaps and cross-currency interest rate swaps ("CCIRs"), to manage certain foreign currency and interest rate exposures.  Derivative instruments are viewed as risk management tools by the Company and are not used for trading or speculative purposes. All derivative instruments are recorded on the Consolidated Balance Sheets at fair value. 

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price).  The Company utilizes market data or assumptions that the Company believes market participants would use in valuing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique.
The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs), and (2) an entity’s own assumptions about market participant assumptions based on the best information available in the circumstances (unobservable inputs).  The fair value hierarchy consists of three broad levels, which give the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). 
The three levels of the fair value hierarchy are described below:
Level 1—Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3—Inputs that are both significant to the fair value measurement and unobservable. 
In instances in which multiple levels of inputs are used to measure fair value, hierarchy classification is based on the lowest level input that is significant to the fair value measurement in its entirety.  The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.
The Company primarily applies the market approach for recurring fair value measurements and endeavors to utilize the best available information.  Accordingly, the Company utilizes valuation techniques that maximize the use of observable inputs, such as forward rates, interest rates, the Company’s credit risk and counterparties’ credit risks, and which minimize the use of unobservable inputs.  The Company is able to classify fair value balances based on the ability to observe those inputs.  Foreign currency exchange forward contracts, interest rate swaps and CCIRs are based upon pricing models using market-based inputs (Level 2).  Model inputs can be verified and valuation techniques do not involve significant management judgment.
The fair value of outstanding derivative contracts recorded as assets and liabilities on the Consolidated Balance Sheets was as follows:
(In thousands)
 
Balance Sheet Location
 
Fair Value of Derivatives Designated as Hedging Instruments
 
Fair Value of Derivatives Not Designated as Hedging Instruments
 
Total Fair Value
December 31, 2018
 
 
 
 
 
 
 
 
Asset derivatives (Level 2):
 
 
 
 
 
 
 
 
Foreign currency exchange forward contracts
 
Other current assets
 
$
2,970

 
$
589

 
$
3,559

Interest rate swaps
 
Other current assets
 
1,331

 

 
1,331

Interest rate swaps
 
Other assets
 
128

 

 
128

Total
 
 
 
$
4,429

 
$
589

 
$
5,018

Liability derivatives (Level 2):
Foreign currency exchange forward contracts
 
Other current liabilities
 
$
24

 
$
2,910

 
$
2,934

Interest rate swaps
 
Other liabilities
 
1,849

 

 
1,849

Total
 
 
 
$
1,873

 
$
2,910

 
$
4,783

December 31, 2017
 
 
 
 
 
 
 
 
Asset derivatives (Level 2):
 
 
 
 
 
 
 
 
Foreign currency exchange forward contracts
 
Other current assets
 
$
2,329

 
$
2,915

 
$
5,244

Interest rate swaps
 
Other current assets
 
464

 

 
464

Interest rate swaps
 
Other assets
 
170

 

 
170

Total
 
 
 
$
2,963

 
$
2,915

 
$
5,878

Liability derivatives (Level 2):
Foreign currency exchange forward contracts
 
Other current liabilities
 
$
153

 
$
6,970

 
$
7,123

Interest rate swaps
 
Other liabilities
 
1,368

 

 
1,368

Total
 
 
 
$
1,521

 
$
6,970

 
$
8,491



All of the Company's derivatives are recorded on the Consolidated Balance Sheets at gross amounts and not offset. All of the Company's interest rate swaps, CCIRs and certain foreign currency exchange forward contracts are transacted under International Swaps and Derivatives Association ("ISDA") documentation. Each ISDA master agreement permits the net settlement of amounts owed in the event of default. The Company's derivative assets and liabilities subject to enforceable master netting arrangements resulted in a $0.1 million and $0.2 million net liability at December 31, 2018 and
December 31, 2017, respectively.









The effect of derivative instruments on the Consolidated Statements of Operations and the Consolidated Statements of Comprehensive Income (Loss):
Derivatives Designated as Hedging Instruments
(In thousands)
 
Amount of
Gain (Loss)
Recognized in
Other
Comprehensive
Income
("OCI") on
Derivative—Effective
Portion
 
Location of Gain
(Loss) Reclassified
from Accumulated
OCI into Income—Effective
Portion
Amount of
Gain (Loss)
Reclassified
from
Accumulated
OCI into
Income—Effective
Portion
 
Location of Gain
(Loss) Recognized
in Income on
Derivative—Ineffective Portion
and Amount
Excluded from
Effectiveness
Testing
Amount of
Gain (Loss)
Recognized
in Income
on Derivative—Ineffective
Portion and
Amount
Excluded
from Effectiveness
Testing
 
Twelve Months Ended December 31, 2018:
Foreign currency exchange forward contracts
 
$
1,935

 
Product revenues / Cost of services and products sold
$
(374
)
 

$

 
Foreign currency forward exchange contracts
 

 
Retained earnings
(1,520
)
(b)
 

 
Interest rate swaps
 
1,451

 
Interest expense
(1,108
)
 
 

 
Cross-currency interest rate swaps
 
63

(a)
Interest expense
1,264

 


 
 
 
$
3,449

 
 
$
(1,738
)
 
 
$

 
 
 
 
 
 
 
 
 
 
 
Twelve Months Ended December 31, 2017:
Foreign currency exchange forward contracts
 
$
3,547

 
Product revenues/Cost of services and products sold
$
(954
)
 

$

 
Interest rate swaps
 
(734
)
 
 

 
 

 
Cross-currency interest rate swaps
 
(205
)
(a)
Interest expense
1,002

 
Cost of services and products sold
420

(c)
 
 
$
2,608

 
 
$
48

 
 
$
420

 
 
 
 
 
 
 
 
 
 
 
Twelve Months Ended December 31, 2016:
Foreign currency exchange forward contracts
 
$
2,294

 
Cost of services and products sold
$
(410
)
 

$

 
Cross-currency interest rate swaps
 
(1,549
)
 
 

 
Cost of services and products sold
4,042

(c)
 
 
$
745

 
 
$
(410
)
 
 
$
4,042

 
(a)
Amounts represent changes in foreign currency translation related to balances in Accumulated other comprehensive loss.
(b)
The Company has adopted the new revenue recognition standard utilizing the modified retrospective transition method, including use of practical expedients. See Note 2, Recently Adopted and Recently Issued Accounting Standards for additional information.
(c)
These gains (losses) offset foreign currency fluctuation effects on the debt principal.

Derivatives Not Designated as Hedging Instruments
 
 
Location of Gain (Loss) Recognized in Income on Derivatives
 
Amount of Gain (Loss) Recognized in Income on Derivatives for the Twelve Months Ended December 31(d)
(In thousands)
 
 
2018
 
2017
 
2016
Foreign currency exchange forward contracts
 
Cost of services and products sold
 
$
17,262

 
$
(23,572
)
 
$
15,875

(d)
These gains (losses) offset amounts recognized in cost of service and products sold principally as a result of intercompany or third-party foreign currency exposures.

Foreign Currency Exchange Forward Contracts
The Company conducts business in multiple currencies and, accordingly, is subject to the inherent risks associated with foreign exchange rate movements.  Foreign currency-denominated assets and liabilities are translated into U.S. dollars at the exchange rates existing at the respective balance sheet dates, and income and expense items are translated at the average exchange rates during the respective periods. 
The Company uses derivative instruments to hedge cash flows related to foreign currency fluctuations.  Foreign currency exchange forward contracts outstanding are part of a worldwide program to minimize foreign currency exchange operating income and balance sheet exposure by offsetting foreign currency exposures of certain future payments between the Company and various subsidiaries, suppliers or customers.  The unsecured contracts are with major financial institutions.  The Company may be exposed to credit loss in the event of non-performance by the contract counterparties.  The Company evaluates the creditworthiness of the counterparties and does not expect default by them.  Foreign currency exchange forward contracts are used to hedge commitments, such as foreign currency debt, firm purchase commitments and foreign currency cash flows for certain export sales transactions.
Changes in the fair value of derivatives used to hedge foreign currency denominated balance sheet items are reported directly in earnings, along with offsetting transaction gains and losses on the items being hedged.  Derivatives used to hedge forecasted cash flows associated with foreign currency commitments may be accounted for as cash flow hedges, as deemed appropriate, if the criteria for hedge accounting are met.  Gains and losses on derivatives designated as cash flow hedges are deferred in Accumulated other comprehensive loss, a separate component of equity, and reclassified to earnings in a manner that matches the timing of the earnings impact of the hedged transactions.  The ineffective portion of all hedges, if any, is recognized currently in earnings.
The recognized gains and losses offset amounts recognized in cost of services and products sold principally as a result of intercompany or third-party foreign currency exposures. At December 31, 2018 and December 31, 2017, the notional amounts of foreign currency exchange forward contracts were $423.9 million and $671.9 million, respectively. These contracts primarily hedge British pounds sterling and euros against other currencies and mature through October 2021.
In addition to foreign currency exchange forward contracts, the Company designates certain loans as hedges of net investments in international subsidiaries. The Company recorded pre-tax net losses of $9.9 million, pre-tax net gains of $17.4 million and pre-tax net losses of $37.5 million related to hedges of net investments during 2018, 2017 and 2016, respectively, in Accumulated other comprehensive loss.
Interest Rate Swaps
The Company uses interest rate swaps in conjunction with certain debt issuances in order to secure a fixed interest rate.  Changes in the fair value attributed to the effect of the swaps’ interest spread and changes in the credit worthiness of the counter-parties are recorded in Accumulated other comprehensive loss. 

In January 2017 and February 2018, the Company entered into a series of interest rate swaps that cover the period from 2018 through 2022 and had the effect of converting $300.0 million of the Term Loan Facility from floating-rate to fixed-rate beginning in 2018.  The fixed rates provided by the swaps replace the adjusted LIBOR rate in the interest calculation, ranging from 1.65% for 2018 to 3.12% for 2022. The total notional of the Company's interest rate swaps was $300.0 million as of December 31, 2018.

Cross-Currency Interest Rate Swaps
The Company may use CCIRs in conjunction with certain debt issuances in order to secure a fixed local currency interest rate. Under these CCIRs, the Company receives interest based on a fixed or floating U.S. dollar rate and pays interest on a fixed local currency rate based on the contractual amounts in dollars and the local currency, respectively. At maturity, there is also the payment of principal amounts between currencies. Changes in the fair value attributed to the effect of the swaps' interest spread and changes in the credit worthiness of the counter-parties are recorded in Accumulated other comprehensive loss. Changes in value attributed to the effect of foreign currency fluctuations are recorded in the Consolidated Statements of Operations and offset currency fluctuation effects on the debt principal. The Company had no outstanding CCIRs at December 31, 2018 or December 31, 2017.
Fair Value of Other Financial Instruments
The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable, accrued liabilities and short-term borrowings approximate fair value due to the short-term maturities of these assets and liabilities. At December 31, 2018 and 2017, the total fair value of long-term debt, including current maturities, was $592.0 million and $599.1 million, respectively, compared with a carrying value of $605.4 million and $593.7 million, respectively. Fair values for debt are based upon pricing models using market-based inputs (Level 2) for similar issues or on the current rates offered to the Company for debt of the same remaining maturities.
Concentrations of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company places cash and cash equivalents with high-quality financial institutions and, by policy, limits the amount of credit exposure to any single institution.
Concentrations of credit risk with respect to accounts receivable are generally limited in the Harsco Industrial Segment. However, the Company's Harsco Metals & Minerals Segment and, to a lesser extent, the Harsco Rail Segment have several large customers throughout the world with significant accounts receivable balances. Consolidation in the global steel or rail industries could result in an increase in concentration of credit risk for the Company.
The Company generally does not require collateral or other security to support customer receivables. If a receivable from one or more of the Company's larger customers becomes uncollectible, it could have a material effect on the Company's results of operations or cash flows.